Asia Pacific In Vitro Diagnostics Market Size, Share & Trends Report

Asia Pacific In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments), By Technology (Immunoassays), By Application, By End use, And Segment Forecasts, 2024 - 2030

Report ID: 978-1-68038-975-3
Number of Report Pages: 80
Format: PDF

Historical Range: 2018 - 2022
Forecast Period: 2024 - 2030
Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
  1.2. Market Definitions
  1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
  1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
  2.1. Market Outlook
  2.2. Segment Outlook
  2.3. Competitive Insights
Chapter 3. Asia Pacific In Vitro Diagnostics Market Variables, Trends, & Scope
  3.1. Market Introduction/Lineage Outlook
  3.2. Market Size and Growth Prospects (USD Million)
  3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
  3.4. Asia Pacific In Vitro Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
  3.4.1.2. Bargaining power of the buyers
  3.4.1.3. Threats of substitution
  3.4.1.4. Threats from new entrants
  3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
  3.4.2.1. Political landscape
  3.4.2.2. Economic and social landscape
  3.4.2.3. Technological landscape
  3.4.2.4. Environmental landscape
  3.4.2.5. Legal landscape
Chapter 4. Asia Pacific In Vitro Diagnostics Market: Product Estimates & Trend Analysis
  4.1. Segment Dashboard
  4.2. Asia Pacific In Vitro Diagnostics Market: Product Movement Analysis, USD Million, 2023 & 2030
  4.3. Reagents and kits
4.3.1. Reagents And Kits In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  4.4. Instruments
4.4.1. Instruments In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  4.5. Services
4.5.1. Services In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Asia Pacific In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
  5.1. Segment Dashboard
  5.2. Asia Pacific In Vitro Diagnostics Market: Technology Movement Analysis, USD Million, 2023 & 2030
  5.3. Immunoassay
5.3.1. Immunoassay In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  5.4. Hematology
5.4.1. Hematology In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  5.5. Clinical Chemistry
5.5.1. Clinical Chemistry In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  5.6. Molecular Diagnostics
5.6.1. Molecular Diagnostics In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  5.7. Coagulation
5.7.1. Coagulation In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  5.8. Microbiology
5.8.1. Microbiology In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  5.9. Others
5.9.1. Other Technologies In Vitro Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Asia Pacific In Vitro Diagnostics Market: Application Estimates & Trend Analysis
  6.1. Segment Dashboard
  6.2. Asia Pacific In Vitro Diagnostics Market: Application Movement Analysis, USD Million, 2023 & 2030
  6.3. Diabetes
6.3.1. Diabetes Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  6.4. Infectious Diseases
6.4.1. Infectious Diseases Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  6.5. Oncology
6.5.1. Oncology Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  6.6. Nephrology
6.6.1. Nephrology Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  6.7. Cardiology
6.7.1. Cardiology Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  6.8. Autoimmune Diseases
6.8.1. Autoimmune Diseases Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  6.9. Drug Testing
6.9.1. Drug Testing Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  6.10. Others
6.10.1. Others Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Asia Pacific In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
  7.1. Segment Dashboard
  7.2. Asia Pacific In Vitro Diagnostics Market: Application Movement Analysis, USD Million, 2023 & 2030 Others
  7.3. Hospitals
7.3.1. Hospitals Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.4. Laboratories
7.4.1. Laboratories Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.5. Homecare Diagnostics
7.5.1. Homecare Diagnostics Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
  7.6. Others
7.6.1. Others Market Revenue Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 8. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
  8.1. In Vitro Diagnostics Market Share, By Country, 2023 & 2030, USD Million
  8.2. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.1. China
  8.2.1.1. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. India
  8.2.2.1. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Japan
  8.2.3.1. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. South Korea
  8.2.4.1. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.5. Thailand
  8.2.5.1. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.6. Australia
  8.2.6.1. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.7. Singapore
  8.2.7.1. Singapore In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.8. Indonesia
  8.2.8.1. Indonesia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
  9.1. Recent Developments & Impact Analysis by Key Market Participants
  9.2. Company Categorization
  9.3. Company Heat Map Analysis
  9.4. Company Profiles
9.4.1. Abbott
  9.4.1.1. Participant’s Overview
  9.4.1.2. Financial Performance
  9.4.1.3. Product Benchmarking
  9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. bioMérieux SA
  9.4.2.1. Participant’s Overview
  9.4.2.2. Financial Performance
  9.4.2.3. Product Benchmarking
  9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. QuidelOrtho Corporation
  9.4.3.1. Participant’s Overview
  9.4.3.2. Financial Performance
  9.4.3.3. Product Benchmarking
  9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Siemens Healthineers AG
  9.4.4.1. Participant’s Overview
  9.4.4.2. Financial Performance
  9.4.4.3. Product Benchmarking
  9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Bio-Rad Laboratories, Inc.
  9.4.5.1. Participant’s Overview
  9.4.5.2. Financial Performance
  9.4.5.3. Product Benchmarking
  9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Qiagen
  9.4.6.1. Participant’s Overview
  9.4.6.2. Financial Performance
  9.4.6.3. Product Benchmarking
  9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Sysmex Corporation
  9.4.7.1. Participant’s Overview
  9.4.7.2. Financial Performance
  9.4.7.3. Product Benchmarking
  9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Charles River Laboratories
  9.4.8.1. Participant’s Overview
  9.4.8.2. Financial Performance
  9.4.8.3. Product Benchmarking
  9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. Quest Diagnostics Incorporated
  9.4.9.1. Participant’s Overview
  9.4.9.2. Financial Performance
  9.4.9.3. Product Benchmarking
  9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Agilent Technologies, Inc.
  9.4.10.1. Participant’s Overview
  9.4.10.2. Financial Performance
  9.4.10.3. Product Benchmarking
  9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. Danaher Corporation
  9.4.11.1. Participant’s Overview
  9.4.11.2. Financial Performance
  9.4.11.3. Product Benchmarking
  9.4.11.4. Recent Developments/ Strategic Initiatives
9.4.12. BD
  9.4.12.1. Participant’s Overview
  9.4.12.2. Financial Performance
  9.4.12.3. Product Benchmarking
  9.4.12.4. Recent Developments/ Strategic Initiatives
9.4.13. F. Hoffmann-La Roche Ltd.
  9.4.13.1. Participant’s Overview
  9.4.13.2. Financial Performance
  9.4.13.3. Product Benchmarking
  9.4.13.4. Recent Developments/ Strategic Initiatives

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.